NIGAM PATEL: Open Payments
NPI 1477656684 · DES PLAINES, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,442 in 125 payments from 28 companies in 2025. Trend: 2023 $2,665 · 2024 $3,104 · 2025 $2,442
Food & beverage: $2,400Education: $43
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 16 | $461 |
| ABBVIE INC. | 16 | $209 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $186 |
| Amgen Inc. | 9 | $184 |
| Indivior Inc. | 7 | $181 |
| Braeburn Inc. | 17 | $153 |
| Xeris Pharmaceuticals, Inc. | 8 | $145 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $119 |
| SANOFI PASTEUR INC. | 4 | $87 |
| Lilly USA, LLC | 3 | $81 |
Products named: Korlym, JARDIANCE, SUBLOCADE, VRAYLAR, BRIXADI, RECORLEV, OTEZLA, Kerendia.
Industry payments across IL — which companies pay providers there.
